Pharma & Biotech BSF Enterprise drops 10.56% as Indigo Capital debt conversion triggers dilution By Ian Lyall 25/08
Pharma & Biotech Lilly's GLP-1 pill hits UK pharmacies as US battle with Novo intensifies By Ian Lyall 24/08
Pharma & Biotech Oxford Nanopore target price hiked to 196p by Panmure Liberum on strategic pivot By Ian Lyall 24/08
Pharma & Biotech EDX Medical jumps 33% after £2.7m 'premium' fundraise to expand health screening By Ian Lyall 24/08
Coal SMALL-CAP MOVERS: The numbers that prove AIM is being bought out from under us By Ian Lyall 21/08
Pharma & Biotech Cancer vaccine breakthrough at Moderna raises hopes for Scancell's melanoma programme By Ian Lyall 20/08
Pharma & Biotech GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth By Ian Lyall 20/08
Pharma & Biotech Shield Therapeutics jumps 11% as losses narrow and profitability target held By Ian Lyall 20/08
Pharma & Biotech Nuformix gains 19% in London trade on positive NXP002 study ahead of ERS Congress By Ian Lyall 19/08
Pharma & Biotech Santhera nears cash break-even as AGAMREE gains traction, Edison says By Ian Lyall 18/08
Pharma & Biotech AstraZeneca maintains Citi 'buy' rating despite mixed pipeline updates By Ephrem Joseph 18/08
Pharma & Biotech Deutsche Bank trims Oxford BioMedica target by 26% after weak trading update By Proactive 18/08
Food & drink Diageo appoints former P&G Beauty chief R. Alexandra Keith to board By Ephrem Joseph 18/08
Medical technology & services HUTCHMED shares rise as lung cancer drug trial hits key targets By Ian Lyall 17/08
